---
figid: PMC11048596__biomedicines-12-00858-g005
figtitle: Significant Genes Associated with Mortality and Disease Progression in Grade
  II and III Glioma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11048596
filename: PMC11048596__biomedicines-12-00858-g005.jpg
figlink: /pmc/articles/PMC11048596/figure/F5
number: F5
caption: Bioinformatics network analysis visualizing the interactions between eight
  significant genes discovered in this research (CER1, FRAT1, FSTL1, RPSA, BMP2, RPL18A,
  RPL19, and RPS12), and twelve independent genes from ten oncogenic signaling pathways
  (E2F2 [cell cycle signaling pathway], CTBP2 [Notch signaling], MAFF [Nrf2 signaling],
  SLC2A3 [Nrf2 signaling], ECSIT [PI3K signaling], HSP90B1 [PI3K signaling], TNFRSF1A
  [PI3K signaling], PAK1 [RTK signaling], ID4 [TGF-β signaling], DDB2 [p53 signaling],
  MDM2 [p53 and cell cycle signaling], and DKK3 [Wnt/β-catenin signaling]) that have
  been significantly associated with prognosis in patients with GBM. The network was
  generated using Cytoscape with the functional enrichment of GO terms and biological
  pathways. CER1, cerberus 1; FRAT1, FRAT regulator of WNT signaling pathway 1; FSTL1,
  follistatin like 1; RPSA, ribosomal protein SA; BMP2, bone morphogenetic protein
  2; RPL18A, ribosomal protein L18A; RPL19, ribosomal protein L19; RPS12, ribosomal
  protein S12; E2F2, E2F transcription factor 2; CTBP2, C-terminal-binding protein
  2; MAFF, MAF bZIP transcription factor F; Nrf2, nuclear factor erythroid 2-related
  factor 2; SLC2A3, solute carrier family 2 member 3; ECSIT, evolutionarily conserved
  signaling intermediate in Toll pathways; PI3K, phosphatidylinositol 3-kinase; HSP90B1,
  heat shock protein 90 kDa beta member 1; TNFRSF1A, tumor necrosis factor receptor
  superfamily member 1A; PAK1, p21 activated kinase 1; RTK, receptor tyrosine kinase;
  ID4, inhibitor of DNA binding 4; TGF-β, transforming growth factor beta; DDB2, damage-specific
  DNA-binding protein 2; MDM2, mouse double minute 2 homolog; DKK3, dickkopf-3; GBM,
  glioblastoma multiforme; GO, gene ontology
papertitle: Significant Genes Associated with Mortality and Disease Progression in
  Grade II and III Glioma
reftext: Bo Mi Choi, et al. Biomedicines. 2024 Apr;12(4).
year: '2024'
doi: 10.3390/biomedicines12040858
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: glioma | Wnt/β-catenin signaling | TCGA | survival | gene
automl_pathway: 0.8742714
figid_alias: PMC11048596__F5
figtype: Figure
redirect_from: /figures/PMC11048596__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11048596__biomedicines-12-00858-g005.html
  '@type': Dataset
  description: Bioinformatics network analysis visualizing the interactions between
    eight significant genes discovered in this research (CER1, FRAT1, FSTL1, RPSA,
    BMP2, RPL18A, RPL19, and RPS12), and twelve independent genes from ten oncogenic
    signaling pathways (E2F2 [cell cycle signaling pathway], CTBP2 [Notch signaling],
    MAFF [Nrf2 signaling], SLC2A3 [Nrf2 signaling], ECSIT [PI3K signaling], HSP90B1
    [PI3K signaling], TNFRSF1A [PI3K signaling], PAK1 [RTK signaling], ID4 [TGF-β
    signaling], DDB2 [p53 signaling], MDM2 [p53 and cell cycle signaling], and DKK3
    [Wnt/β-catenin signaling]) that have been significantly associated with prognosis
    in patients with GBM. The network was generated using Cytoscape with the functional
    enrichment of GO terms and biological pathways. CER1, cerberus 1; FRAT1, FRAT
    regulator of WNT signaling pathway 1; FSTL1, follistatin like 1; RPSA, ribosomal
    protein SA; BMP2, bone morphogenetic protein 2; RPL18A, ribosomal protein L18A;
    RPL19, ribosomal protein L19; RPS12, ribosomal protein S12; E2F2, E2F transcription
    factor 2; CTBP2, C-terminal-binding protein 2; MAFF, MAF bZIP transcription factor
    F; Nrf2, nuclear factor erythroid 2-related factor 2; SLC2A3, solute carrier family
    2 member 3; ECSIT, evolutionarily conserved signaling intermediate in Toll pathways;
    PI3K, phosphatidylinositol 3-kinase; HSP90B1, heat shock protein 90 kDa beta member
    1; TNFRSF1A, tumor necrosis factor receptor superfamily member 1A; PAK1, p21 activated
    kinase 1; RTK, receptor tyrosine kinase; ID4, inhibitor of DNA binding 4; TGF-β,
    transforming growth factor beta; DDB2, damage-specific DNA-binding protein 2;
    MDM2, mouse double minute 2 homolog; DKK3, dickkopf-3; GBM, glioblastoma multiforme;
    GO, gene ontology
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RPSA
  - RPL19
  - FRAT1
  - CTBP2
  - ROBO1
  - ROBO2
  - ROBO3
  - RPS12
  - MRPS12
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DKK3
  - BMP2
  - DDB2
  - RPL18A
  - C6
  - FSTL1
  - MDM2
  - ID4
  - E2F2
  - TNFRSF1A
  - SLC2A3
  - MAFF
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - BMP1
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - CER
  - cancer
  - Malignant pleural mesothelioma
---
